Xilio Therapeutics reports Q1 results (XLO:NASDAQ)
Xilio Therapeutics press release (XLO): Q1 Revenue of $12.6M. Net Loss: Net loss was $9.5 million for the quarter ended March 31, ...
Wednesday, May 13, 2026
Tag: XLONASDAQ
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.